IlanaCassMD

Obstetrics & Gynecology • Lebanon, NH

Gynecologic Oncology

Chair , Department of Obstetrics and Gynecology Professor of Obstetrics & Gynecology, Dartmouth Hitchcock Medical Center

Join to view full profile

Dr. Cass is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cass' full profile

Already have an account?

Office
Dartmouth-Hitchcock Medical Center, Obsterics and Gynecology
One Medical Center Drive
Lebanon, NH 03756

Education & Training

Yale-New Haven Medical CenterResidency, Obstetrics and Gynecology, 1991 - 1995
Icahn School of Medicine at Mount SinaiClass of 1991

Certifications & Licensure

VT State Medical License 2022 - 2026
CA State Medical License 1998 - 2025
NH State Medical License 2019 - 2025
FL State Medical License 2013 - 2015
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Top Doctors:LA Area Castle Connolly, 2013
Top Doctors:Southern California Castle Connolly, 2012
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
Active, not recruiting
Phase 3
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
Active, not recruiting
Phase 3
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Jan 19
Active, not recruiting
Not Applicable
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Start of enrollment: 2010 Apr 01
Completed
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Correlation of histopathologic findings with clinical predictors of disease recurrence and progression to vulvar carcinoma in patients with differentiated vulvar intra...
Jill N T Roberts, Jessica L Bentz, Robert E LeBlanc, Ilana Cass
Gynecologic Oncology Reports. 2024-04-01
1 citations
Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
Zachary P Schwartz, Andrew J Li, Christine S Walsh, B J Rimel, Monica M Alvarado
Gynecologic Oncology. 2023-06-01
44 citations
Single-cell transcriptomic analysis of endometriosis.
Marcos A S Fonseca, Marcela Haro, Kelly N Wright, Xianzhi Lin, Forough Abbasi
Nature Genetics. 2023-02-01

Lectures

Advances in Health Care for Women Over 40 2012
Contemporary Forums, Las Vegas, Nevada - 5/17/2012

Press Mentions

New Self-Swab HPV Test Is an Alternative to Pap Smears. Here's How It WorksSeptember 25th, 2024
Shop TalkMarch 20th, 2020
ACOG Experts Debate Salpingectomy to Reduce Ovarian Cancer Risk at Annual MeetingMay 4th, 2019
Join now to see all

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow